You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 12, 28 JUNE 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (112)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of a Portable Prothrombin Time Monitor for Home Use by Patients Who Require Long-term Oral Anticoagulant Therapy

David R. Anderson, MD; Linda Harrison, RN; Jack Hirsh, MD

Arch Intern Med. 1993;153(12):1441-1447.


Abstract

Background
The anticoagulant activity of warfarin sodium is monitored by the prothrombin time (PT). The introduction of a portable PT monitor has raised the possibility that patients could reduce the inconvenience of anticoagulant therapy by measuring their PT at home. We performed this study to determine the feasibility and accuracy of home use of the portable PT monitor.

Methods
A prospective cohort study was performed in consecutive eligible patients who required long-term anticoagulant therapy. Patients performed multiple measurements of their PT at home by means of the portable monitor and at their usual laboratory within a 4-hour interval. The accuracy of the portable monitor was evaluated by two criteria for agreement. Standard agreement was achieved if the portable monitor and laboratory results were both either within or outside the patient's targeted therapeutic range or if the two results were within 0.4 international normalized ratio units of each other. Expanded agreement was achieved if both the portable monitor and laboratory results were within ±0.4 international normalized ratio units of the targeted therapeutic range.

Results
Forty patients (19 men and 21 women, aged 25 to 74 years) were followed up for 6 to 24 months by means of the portable PT monitor. The mean level of agreement achieved per patient was 83% (95% confidence interval, 79% to 87%) by the standard criteria and 96% (95% confidence interval, 94% to 98%) by the expanded criteria. Twenty-seven patients (68%) and 39 patients (98%) achieved more than 80% agreement by the standard and the expanded criteria, respectively. Questionnaire results revealed that 97% of the patients preferred using the portable monitor to measure their PT.

Conclusions
Patients receiving long-term anticoagulant therapy achieved a high rate of clinically important agreement between self-measurements of the PT with the use of a portable monitor and laboratory PT results. Patients strongly preferred using the portable monitor to measure their PT levels. The use of the portable monitor as the primary method for measuring the PT can be recommended in selected patients receiving long-term anticoagulant treatment.

(Arch Intern Med. 1993;153:1441-1447)



Author Affiliations

From the Hamilton (Ontario) Civic Hospitals Research Centre and the Department of Medicine, McMaster University, Hamilton.; Dr Anderson is now with Victoria General Hospital, Halifax, Nova Scotia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Validity of Criteria Used to Evaluate Fingerstick Devices That Assess International Normalized Ratio
Shermock et al.
Med Decis Making 2006;26:239-246.
ABSTRACT  

Anticoagulation Monitoring Part 1: Warfarin and Parenteral Direct Thrombin Inhibitors
Spinler et al.
The Annals of Pharmacotherapy 2005;39:1049-1055.
ABSTRACT | FULL TEXT  

The Value of Home Monitoring Kits in Diabetes, Hypertension, Asthma, and Oral Anticoagulation Therapy
Vincze and Parthan
Journal of Pharmacy Practice 2004;17:182-196.
ABSTRACT  

Infection and inflammation and the coagulation system
Levi et al.
Cardiovasc Res 2003;60:26-39.
ABSTRACT | FULL TEXT  

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy
Hirsh et al.
J Am Coll Cardiol 2003;41:1633-1652.
FULL TEXT  

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Hirsh et al.
Circulation 2003;107:1692-1711.
FULL TEXT  

Is Percutaneous Left Atrial Appendage Transcatheter Occlusion an Alternative to Oral Anticoagulation in Patients With Atrial Fibrillation? * Response
Stollberger et al.
Circulation 2003;107 :e11-e12.
FULL TEXT  

A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management
Fitzmaurice et al.
J. Clin. Pathol. 2002;55:845-849.
ABSTRACT | FULL TEXT  

Home management of anticoagulation
Voller et al.
Eur Heart J Suppl 2001;3:Q44-Q49.
ABSTRACT  

Economic analysis of bleeding and thromboembolic sequelae after heart valve replacement (GELIA 7)
Muller et al.
Eur Heart J Suppl 2001;3:Q65-Q69.
ABSTRACT  

Recommendations for patients undertaking self management of oral anticoagulation
Fitzmaurice and Machin
BMJ 2001;323:985-989.
FULL TEXT  

Anticoagulation in patients with thromboembolic disease
Tait
Thorax 2001;56:ii30-37.
FULL TEXT  

Thrombophilia: What's a Practitioner to Do?
Macik et al.
ASH Education Book 2001;2001:322-338.
ABSTRACT | FULL TEXT  

Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119 :22S-38S.
FULL TEXT  

A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin: A Randomized, Controlled Trial
Beyth et al.
ANN INTERN MED 2000;133:687-695.
ABSTRACT | FULL TEXT  

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism
Ansell et al.
ASH Education Book 2000;2000:266-284.
ABSTRACT | FULL TEXT  

Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 Patients
Streif et al.
Blood 1999;94:3007-3014.
ABSTRACT | FULL TEXT  

Systematic review of near patient test evaluations in primary care
Delaney et al.
BMJ 1999;319:824-827.
ABSTRACT | FULL TEXT  

A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation: A Randomized Controlled Trial
Sawicki and for the Working Group for the Study of Patient Sel
JAMA 1999;281:145-150.
ABSTRACT | FULL TEXT  

Empowering Patients to Monitor and Manage Oral Anticoagulation Therapy
Ansell
JAMA 1999;281:182-183.
FULL TEXT  

Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring
Ezekowitz et al.
J CARDIOVASC PHARMACOL THER 1999;4:3-8.
ABSTRACT  

Long-term Patient Self-management of Oral Anticoagulation
Ansell et al.
Arch Intern Med 1995;155:2185-2189.
ABSTRACT  

Accuracy of Laboratory and Portable Monitor International Normalized Ratio Determinations: Comparison With a Criterion Standard
Kaatz et al.
Arch Intern Med 1995;155:1861-1867.
ABSTRACT  

HOME MONITORING OF THE PROTHROMBIN TIME
JWatch General 1993;1993:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.